Olopatadine Hcl 0.1% Ophthalmic Solution
Sector: Aerospace & Defense • Location: Ontario, Canada
Source: SAM.gov
Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00
- Status
- Closed
- Sector
- Aerospace & Defense, Seaport, Commercial, Residential, Manufacturing (Industrial), Warehouse, Hospital
- Location
- Ontario, Canada
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about Olopatadine Hcl 0.1% Ophthalmic Solution
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | award notice |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle |
Original sector | Not Identified |
Budget |
Location
Country | Canada |
State | Canada |
City | Ontario |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Aerospace & Defense, Seaport, Commercial, Residential, Manufacturing (Industrial), Warehouse, Hospital |
Article published date | 2026-05-05 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
More Aerospace & Defense tenders in Canada
- Region / Affretement d'helicopteres saisonniers
- Provincial - Affrètement d'hélicoptères court terme
- Plusieurs régions / Plusieurs sites - Affrètement d'hélicoptères long terme
- Côte-Nord/Nord-du-Québec / Plusieurs sites - Affrètement d'hélicoptères long terme saisonniers
- Provincial – Services de diffusion de formation pour le pilotage de systèmes d’aéronefs télépilotés
- Photographies thématiques et de reportage
- Provincial – Services de diffusion de formation pour le pilotage de systèmes d’aéronefs télépilotés
- Olopatadine Hcl 0.1% Ophthalmic Solution